Trending Now
EyePoint Pharmaceutical Inc. (NASDAQ:EYPT) Reports Revenue Of $15.7 Million In Q3...
EyePoint Pharmaceutical Inc. (NASDAQ:EYPT) has announced Q3 2020 financial results and provided its recent corporate development updates.
DEXYCU and YUTIQ net sales of $5.8 million
The...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Zafgen Inc. (NASDAQ:ZFGN) Announces Reverse Merger With Chondrial Therapeutics With New...
Zafgen Inc. (NASDAQ:ZFGN) and Chondrial Therapeutics Inc. have announced the finalization of a reverse merger transaction forming a new public company. The combined biotechnology...
MAKE IT MODERN
LATEST REVIEWS
SPY bounces back (AAPL,XLE,XLF)
Markets had a rough morning and have bounced back nicely, looking to end the day relatively flat. This creates a doji type...
MAKE IT MODERN
PERFORMANCE TRAINING
Aion Therapeutic Inc. (CNSX:AION) Confirms Management Appointment Amid Debentures Restructuring
Formerly known Osoyoos Cannabis Inc., Aion Therapeutic Inc. (CNSX:AION) researches, grows, and markets medical cannabis in Canada. The company has carried out a number...
InflaRx (NASDAQ:IFRX) Commence Phase III Study Of IFX-1 In Treatment Of Severe COVID-19 Induced...
InflaRx (NASDAQ:IFRX) has announced the third phase of Phase II/III study with IFX-1 in severe coronavirus induced pneumonia. The company initiated the first enrolment...
Precigen Inc (NASDAQ: PGEN) Announces Definitive Agreement For The Sale Of Tran Ova Genetics...
Precigen Inc (NASDAQ: PGEN) has announced a definitive agreement to sell its wholly-owned animal reproductive technology subsidiary Trans Ova Genetics L.C. to URUS for...
Junior Miner Blue Lagoon (BLAGF) Poised for Promising Non-Dilutive Exploration Push as New Gold...
After wallowing in a sideways consolidation for the past two years, gold is breaking out once again. The yellow metal blew through...
The US FDA Grants Fast Track Designation To IND – LB1148 Of Palisade Bio...
The US FDA granted fast track designation to Palisade Bio Inc (NASDAQ:PALI)’s LB1148 to treat adhesions following pelvic or abdominal surgery.
MAKE IT MODERN
